aGraduate School of Public Health, Seoul National University, Seoul, Korea
bHealth Promotion Research Institute, Korea Association of Health Promotion, Seoul, Korea
cGraduate School of Public Health & Institute for Health Environment, Seoul National University, Seoul, Korea
© 2014 Published by Elsevier B.V. on behalf of Korea Centers for Disease Control and Prevention.
This is an Open Access article distributed under the terms of the CC-BY-NC License (http://creativecommons.org/licenses/by-nc/3.0).
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Prevalence of MetS components |
Men (n = 93) |
Women (n = 170) |
||||||||
---|---|---|---|---|---|---|---|---|---|---|
EBP | AO | IFG | ETG | HDL |
O |
E |
O/E |
O |
E |
O/E |
n (%) | (%) | n (%) | (%) | |||||||
+ | + | + | + | + | 3 (3.2) | 4.7 | 0.68 | 2 (1.2) | 9.5 | 0.12 |
+ | + | + | + | − | 20 (21.5)*** | 35.2 | 0.61 | 7 (4.1) | 12.0 | 0.34 |
+ | + | + | − | + | 0 (0.0) | 1.4 | 0.00 | 4 (2.4) | 5.4 | 0.43 |
+ | + | − | + | + | 0 (0.0) | 1.3 | 0.00 | 10 (5.9) | 6.9 | 0.85 |
+ | − | + | + | + | 2 (2.2) | 1.4 | 1.56a | 0 (0.0) | 1.5 | 0.00 |
− | + | + | + | + | 0 (0.0) | 0.8 | 0.00 | 8 (4.7) | 4.5 | 1.04 |
+ | + | + | − | − | 20 (21.5) | 10.3 | 2.09a | 42 (24.7) | 6.9 | 3.59a |
+ | + | − | + | − | 15 (16.1) | 9.7 | 1.67a | 19 (11.2) | 8.8 | 1.27 |
+ | + | − | − | + | 0 (0.0) | 0.4 | 0.00 | 13 (7.6) | 4.0 | 1.92a |
+ | − | + | + | − | 15 (16.1)** | 10.3 | 1.57a | 8 (4.7) | 1.9 | 2.51a |
+ | − | + | − | + | 0 (0.0) | 0.4 | 0.00 | 2 (1.2) | 0.9 | 1.39 |
+ | − | − | + | + | 4 (4.3) | 0.4 | 11.39a | 8 (4.7) | 1.1 | 4.33a |
− | + | + | + | − | 12 (12.9) | 6.2 | 2.07a | 19 (11.2) | 5.7 | 1.95a |
− | + | + | − | + | 1 (1.1) | 0.2 | 4.40a | 1 (0.6) | 2.6 | 0.23 |
− | + | − | + | + | 1 (1.1) | 0.2 | 4.69a | 22 (12.9)** | 3.3 | 3.90a |
− | − | + | + | + | 0 (0.0) | 0.2 | 0.00 | 5 (2.9) | 0.7 | 4.16a |
**p < 0.01 and ***p < 0.001 based on Chi-square tests and Fisher's exact tests for categorical variables.
AO = abdominal obesity; E = expected prevalence rates; EBP = elevated blood pressure; ETG = elevated triglycerides; HDL = low high-density lipoprotein cholesterol; IFG = impaired fasting glucose; MetS = metabolic syndrome; O = observed prevalence rates.
Changes in MetS components |
Men |
Women |
|||||
---|---|---|---|---|---|---|---|
O |
E |
O/E |
O |
E |
O/E | ||
(%) | (%) | (%) | (%) | ||||
EBP | AO | 5.17 | 6.75 | 0.77 | 8.25 | 9.94 | 0.83 |
EBP | IFG | 11.67 | 9.16 | 1.27 | 18.46 | 15.44 | 1.20 |
EBP | ETG | 18.64 | 11.81 | 1.58a | 27.78 | 25.12 | 1.11 |
EBP | HDL | 44.44 | 13.81 | 3.22a | 15.38 | 15.30 | 1.00 |
AO | IFG | 7.14 | 6.70 | 1.07 | 6.02 | 5.64 | 1.07 |
AO | ETG | 9.80 | 8.64 | 1.13 | 14.94 | 9.17 | 1.63a |
AO | HDL | 20.00 | 10.10 | 1.98a | 11.67 | 5.59 | 2.09a |
IFG | ETG | 13.46 | 11.72 | 1.15 | 12.24 | 14.25 | 0.86 |
IFG | HDL | 16.67 | 13.70 | 1.22 | 4.55 | 8.68 | 0.52 |
ETG | HDL | 40.00 | 17.68 | 2.26a | 18.18 | 14.12 | 1.29 |
*p < 0.05, ***p < 0.001.
AO = abdominal obesity; E = expected prevalence rates; EBP = elevated blood pressure; ETG = elevated triglycerides; HDL = low high-density lipoprotein cholesterol; IFG = impaired fasting glucose; MetS = metabolic syndrome; O = observed prevalence rates; POR = prevalence odds ratio adjusted for ages.